An unexpected N‐substituted oxindole: 1‐(3,3,5‐trimethyl‐2‐phenyl‐1,2‐oxazolidin‐5‐yl)‐1H‐indol‐3(2H)‐one

By  

Acta Crystallographica Section E, Vol. 63, Iss. 2, 2007-02 ,pp. : o877-o878

John Wiley & Sons Inc

Access to resources Recommend Favorite

N‐[(3‐Methyl‐1‐phenyl­sulfonyl‐1H‐indol‐2‐yl)meth­yl]‐1,1‐dioxo‐1‐benzo[d]isothia­zol‐3(2H)‐one

By  

Acta Crystallographica Section E, Vol. 63, Iss. 4, 2007-04 ,pp. : o2026-o2028

John Wiley & Sons Inc

Access to resources Recommend Favorite

1‐Acetyl‐3,3‐bis­[3‐(4‐methyl­phen­yl)‐1,2,4‐oxa­diazol‐5‐ylmeth­yl]‐1H‐indol‐2(3H)‐one

By  

Acta Crystallographica Section E, Vol. 62, Iss. 6, 2006-06 ,pp. : o2462-o2463

John Wiley & Sons Inc

Access to resources Recommend Favorite

(1′S,2′S,5′R)‐3‐(2‐Bromo­propion­yl)‐2′‐isopropyl‐5′‐methyl­spiro­[2H‐1,3‐benzoxazine‐2,1′‐cyclo­hexa­n]‐4(3H)‐one

By  

Acta Crystallographica Section E, Vol. 62, Iss. 7, 2006-07 ,pp. : o3011-o3012

John Wiley & Sons Inc

Access to resources Recommend Favorite

(S)‐2‐(1‐Benzyl‐5‐bromo‐1H‐indol‐3‐yl)‐2‐hydroxy‐N‐methylacetamide

By  

Acta Crystallographica Section E, Vol. 63, Iss. 7, 2007-07 ,pp. : o3261-o3261

John Wiley & Sons Inc

Access to resources Recommend Favorite